Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Divis Laboratories is coming after a while because after the stock was correcting then it was going up but not in the same galloping fashion as most of the other stocks. Yesterday, it had a good day, it went up, now it is on the verge of breaking out and making new highs."
He further added, "We can anticipate that breakout. If it does not happen in the morning, it may happen in the afternoon or tomorrow and take a long position. It is in the F&O section, so long positions are easy to take. Some defensive, some pharmaceutical stocks will outperform, Divis Laboratories is likely to be one of them."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
